Depression and coronary heart disease

Current Atherosclerosis Reports

Volumn 12, Issue 2, 2010, Pages 105-109

  Khan, Faisal Mahmood ^a   Kulaksizoglu, Burak ^b   Cilingiroglu, Mehmet ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Antalya Teaching and Research Hospital   (Turkey)

Author keywords

Coronary artery disease; Depression; Risk factors

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CARDIOTOXICITY; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PROGNOSIS; REVIEW; SUDDEN DEATH; COMPLICATION; CORONARY DISEASE; MENTAL STRESS; PSYCHOLOGY; RISK FACTOR;

CORONARY DISEASE; DEPRESSION; HUMANS; PROGNOSIS; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 77953541937     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-010-0096-5     Document Type: Review

References (21)

1. Kessler RC, Berglund P, Demler O, et al.: The epidemiology of major depressive disorder: results from the National Co morbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
2. Frasure-Smith N, Lespérance F: Recent evidence linking coronary heart disease and depression. Can J Psychiatry 2006, 51:730-737.
3. Carney RM, Freedland KE, Rich MW, Jaffe AS: Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms. Ann Behav Med 1995, 17:142-149.
4. Glassman AH, Shapiro PA: Depression and the course of coronary artery disease. Am J Psychiatry 1998, 155:4-111.
5. Malzberg B: Mortality among patients with involution melancholia. Am J Psychiatry 1937, 93:1231-1238.
6. Glassman AH, Stetner F, Walsh BT, et al.: Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988, 259:2863-2866.
7. Haines AP, Imeson JD, Meade TW: Phobic anxiety and ischaemic heart disease. BMJ 1987, 295:297-299.
8. Kawachi I, Colditz GA, Ascherio A, et al.: Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994, 89:1992-1997. (Pubitemid 24142773)
9. Chida Y, Steptoe A: The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol 2009, 53:936-946.
10. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al.: Recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2008, 118:1768-1775. These are screening guidelines developed by the American Heart Association.
11. Thombs BD, de Jonge P, Coyne JC, et al.: Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 2008, 300:2161-2171.
12. Berkman LF, Blumenthal J, Burg M, et al; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD): Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003, 289:3106-3116.
13. Glassman AH, O'Connor CM, Califf R, et al.: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701-709.
14. Lespérance F, Frasure-Smith N, Koszycki D, et al.: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007, 297:367-379.
15. Nicholson A, Kuper H, Hemingway H: Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006, 27:2763-2774.
16. Whooley MA, de Jonge P, Vittinghoff E, et al.: Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008, 300:2379-2388.
17. Whang W, Kubzansky LD, Kawachi I, et al.: Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol 2009, 53:950-958.
18. Skala JA, Freedland KE, Carney RM: Depressive symptoms and functional status in patients with congestive heart failure. Ann Behav Med 1995, 17:S134.
19. Druss BG, Bradford DW, Rosenheck RA, et al.: Mental disorders and use of cardiovascular procedures after myocardial infarction. J Am Med Assoc 2000, 283:506-511.
20. Laghrissi-Thode F, Wagner RW, Pollock BG, et al.: Elevated platelet factor 4 and b-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997, 42:290-295.
21. Pollock BG, Laghrissi-Thode F, Wagner WR: Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol 2000, 20:137-140.